RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
#weHaveMS @drbarrysinger shares this study showing divergent views on MS treatment between clinicians and PwMS. No surprise here - what’s important to people with MS is much more than measurable clinical outcomes
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
RT @drbarrysinger: What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living wit…
What's your ideal #MS treatment to improve symptoms and daily functioning? Check out the priorities of people living with MS vs. MS neurologists. My latest publication: https://t.co/6wBLfBw03n @AaronBosterMD @Brandon_Beaber @KlausSchmierer @C_OrejaGuevara
RT @Lyfebulb: Patient and Clinician Perspectives for Multiple Sclerosis | PPA https://t.co/LGh41WtKDj #chronicillness #digitalhealth #lyfe…
Patient and Clinician Perspectives for Multiple Sclerosis | PPA https://t.co/LGh41WtKDj #chronicillness #digitalhealth #lyfebulb https://t.co/lxOasorflb
New article: A Study Comparing Patient and Clinician Perspectives of Treatments for Multiple Sclerosis via Group Concept Mapping https://t.co/10Chy8UqHu #MS #multiplesclerosis #neurology https://t.co/z1rDnYDGhm